Clinical efficacy and safety analysis of thoracoscopic surgery in the treatment of chronic empyema
胸腔镜手术治疗慢性脓胸的临床疗效及安全性分析

摘要

目的 分析胸腔镜手术治疗慢性脓胸的临床疗效及安全性。方法 于2021年04月-2023年05月期间，选取116例慢性脓胸患者为研究对象，将所有患者均分为两组，其中对照组（n=58）采用传统的开胸手术治疗方法，观察组（n=58）采用胸腔镜手术治疗方法，对手术治疗的疗效及安全性进行对比分析。结果 观察组的临床治疗效果高于照组（P＜0.05）；观察组的手术各项指标优于对照组（P＜0.05）；观察组术后生活质量评分于对照组（P＜0.05）；观察组术后并发症的发生率低于对照组（P＜0.05）。结论 采用胸腔镜手术治疗慢性脓胸，其临床治疗效果十分显著，而且手术的安全性更高，术后患者不仅恢复较快，其术后并发症也较少。

Abstract

Objective To analyze the clinical efficacy and safety of thoracoscopic surgery in the treatment of chronic empyema.
Methods From April 2021 to May 2023, 116 patients with chronic empyema were selected as the study subjects, and all patients were divided into two groups, including the control group (n=58) treated with traditional thoracotomy and the observation group (n=58) treated with thoracoscopic surgery.
Results The clinical treatment effect of the observation group was higher than that of the control group (P<0.05), the surgical indexes of the observation group were better than those of the control group (P<0.05), the postoperative quality of life score of the observation group was higher than that of the control group (P<0.05), and the incidence of postoperative complications in the observation group was lower than that of the control group (P<0.05).
Conclusion   Thoracoscopic surgery for the treatment of chronic empyema has a significant clinical effect, and the safety of the operation is higher, and the postoperative patients not only recover faster, but also have fewer postoperative complications.